Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by stockman6767on May 09, 2019 12:33pm
96 Views
Post# 29729559

Theft by regulation

Theft by regulationIt is very sad when the very regulations that should protect the public are themselves the roadmap for how the wealthy steal from the unwary retail public investor! They knew of the hardship application and connived with management  to rubber stamp this "hardship application" even though it did NOT EXIST to deny the shareholders their rightful vote and valuation without which the takeover "restructure" totally on SALP dictated terms would not have been possible!!
Bullboard Posts